Physician

Leonid Shunyakov, MD

According to 2025 Medicare claims, Leonid Shunyakov, MD (NPI: 1396709895) practices medical oncology in the Springfield, MO market, with the plurality of this provider's patient population coming from Polk, MO. This provider's primary affiliated billing organization is CENTRAL CARE, PA (NPI: 1578532081; TIN: 48-1125116) and primary practice location at 65613-3020.

Shunyakov's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 379 traditional Medicare patients, billed 315,201 HCPCS/CPT codes, and received $6,260,103 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 5,150 prescription claims across 490 beneficiaries totaling $12,046,246 in drug costs, led by Revlimid (Lenalidomide). DME data shows 37 claims. Open Payments data shows 454 records totaling $363,395. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $3,878,298 to $12,046,246. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $33,605 to $2,739.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	577	277,072	$3,808,701
2016	633	339,894	$4,814,183
2017	539	377,204	$5,133,838
2018	590	525,649	$6,245,089
2019	595	458,843	$5,640,454
2020	641	542,398	$6,698,185
2021	574	410,172	$5,474,237
2022	520	308,189	$5,879,843
2023	433	278,902	$6,163,698
2024	379	315,201	$6,260,103

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	403	4,525	$3,878,298
2016	447	5,420	$5,825,586
2017	413	4,993	$5,377,828
2018	488	5,140	$6,901,777
2019	523	6,000	$8,190,139
2020	570	5,709	$7,876,734
2021	547	4,498	$8,804,470
2022	515	4,513	$9,895,038
2023	480	4,789	$11,967,088
2024	490	5,150	$12,046,246

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	46	448	$89,669
2016	40	345	$89,877
2017	27	191	$21,246
2018	45	309	$32,478
2019	23	161	$15,482
2020	27	227	$13,931
2021	27	216	$15,405
2022	30	145	$6,940
2023	24	178	$29,105
2024	N/R	37	$2,644

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	312	1,558	$92
96413	Administration of chemotherapy into vein, 1 hour or less	87	608	$89
96523	Irrigation of implanted venous access drug delivery device	84	237	$16
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	186	328	$13
96372	Injection of drug or substance under skin or into muscle	99	618	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	150	3,927	$2,352,954
Pomalyst	Pomalidomide	42	1,155	$909,649
Ibrance	Palbociclib	52	1,456	$796,775
Verzenio	Abemaciclib	49	1,372	$786,405
Truqap	Capivasertib	24	742	$467,128

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	25	$2,205
J8521	Capecitabine, oral, 500 mg	N	N/R	12	$439

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	426	$317,040	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	28	$46,355	Genentech, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Leonid Shunyakov, MD?

Tedicare shows public-source Medicare data for Leonid Shunyakov, MD (NPI 1396709895), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Leonid Shunyakov, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Leonid Shunyakov, MD?

Leonid Shunyakov, MD is linked to CENTRAL CARE, PA (billing NPI 1578532081) in the available physician profile data.

Does Leonid Shunyakov, MD have Open Payments data?

Leonid Shunyakov, MD has 454 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.